ESC 365 - Improving venous thromboembolism treatment in clinical practice: NOACs vs low-molecular-weight heparin/vitamin K antagonists / NOACs

ESC Premium Access

Improving venous thromboembolism treatment in clinical practice: NOACs vs low-molecular-weight heparin/vitamin K antagonists / NOACs

Session: Anticoagulation for the management of venous thromboembolism in the non-vitamin K antagonist oral anticoagulant (NOAC) era

Topic: Venous Thromboembolism

Speaker: Doctor A. Cohen (London, GB)

Sponsored by The Bristol-Myers Squibb/Pfizer Alliance

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Alexander Thomas Cohen

Guy's and St Thomas' NHS Trust Hospitals, London (United Kingdom of Great Britain & Northern Ireland)

17 presentations

0 follower

4 more presentations in this session

The evolving landscape of anticoagulation in venous thromboembolism

Speaker: Professor S. Konstantinides (Mainz, DE)

Clinical dilemmas in venous thromboembolism management

Speaker: Professor C. Ay (Vienna, AT)

Exploring NOACs in the management of cancer-associated thrombosis

Speaker: Professor G. Agnelli (Perugia, IT)

Questions and answers - Anticoagulation for the management of venous thromboembolism

Speaker: Professor S. Konstantinides (Mainz, DE)

Access the full session

Anticoagulation for the management of venous thromboembolism in the non-vitamin K antagonist oral anticoagulant (NOAC) era

Speakers: Doctor A. Cohen, Professor S. Konstantinides, Professor C. Ay, Professor G. Agnelli, Professor S. Konstantinides

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources